GG
BSX icon

Gofen & Glossberg’s Boston Scientific BSX Stock Holding History

Gofen & Glossberg’s Portfolio BSX Stock Details BSX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		$626K Hold
13,531
– – 0.02% 308
2022
Q3 		$524K Hold
13,531
– – 0.01% 307
2022
Q2 		$504K Hold
13,531
– – 0.01% 318
2022
Q1 		$599K Buy
+13,531
New +$586K 0.01% 308

Other funds holding BSX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
BG
Bollard Group Boston, Massachusetts $3.39B AUM 1.06% 1-Year Est. Return

Gofen & Glossberg's BSX Position: Q4 2022 in Review

Gofen & Glossberg held its Boston Scientific (BSX) position steady in Q4 2022 at 13,531 shares worth $626K. The position accounts for 0.02% of the portfolio, ranked #308.

Gofen & Glossberg first reported a position in BSX in Q1 2022 and has held it in 4 quarters since. 929 funds tracked by Wall St. Rank hold BSX as of Q4 2022.

  • Gofen & Glossberg held 13,531 shares of Boston Scientific worth $626K as of Q4 2022.
  • Gofen & Glossberg left its Boston Scientific share count unchanged in Q4 2022.
  • Boston Scientific made up 0.02% of Gofen & Glossberg's portfolio in Q4 2022, its #308 holding.
  • Gofen & Glossberg first reported a position in Boston Scientific in Q1 2022 and has held it in 4 quarters since.
  • 929 funds tracked by Wall St. Rank held Boston Scientific as of Q4 2022.

Based on Gofen & Glossberg's 13F filing for Q4 2022, filed 13 Jan 2023.